Neil Bence: Manipulating Degradation

Senior Scientist, Millennium Pharmaceuticals: The Takeda Oncology Company Age: 39

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© LIZ LINDER PHOTOGRAPHYNeil Bence loves science so much that after nearly eight years of working toward his PhD, “I had to throw him out of the lab,” says his graduate advisor, Stanford University cell biologist Ron Kopito. Never before, Kopito says, had a graduate student taken such joy in his project that he just kept working, well beyond amassing enough data to finish.

As an undergrad at the University of California, Davis, Bence studied DNA damage repair pathways in plants. “That’s where I cut my teeth in terms of doing bench work and learning the work ethic, the 24–7 mentality of doing research,” he says. Bence thought he would continue working on plant biochemistry as a graduate student, but after a rotation through Kopito’s human cell biology lab in 1996, he changed his mind. METHODS: At the time, Kopito’s lab was refocusing its efforts from endoplasmic reticulum–associated protein degradation in cystic fibrosis to the relevance of misfolded protein aggregations to neurodegenerative diseases. “Just as I was getting comfortable with studying the secretory pathway and ion channels, all of a sudden we were turning into a neurodegeneration lab,” Bence ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies